Vitamin D (25-hydroxy) Test · Blood

Most people assume their vitamin D is fine because they spend some time outdoors and eat a reasonable diet. But vitamin D deficiency is remarkably common, affecting roughly one in four U.S. adults, and it rarely announces itself with obvious symptoms until the damage is well underway. By the time you notice bone pain, muscle weakness, or unexplained fatigue, your levels may have been low for years.

This test measures 25-hydroxyvitamin D (25(OH)D), the form your liver produces from all vitamin D sources combined. Because it circulates in your blood for several weeks (unlike the active hormonal form, which lasts only hours), it gives the most reliable snapshot of your overall vitamin D status. It is not included in any standard blood panel, so unless you or your doctor specifically order it, you will never know your number.

What This Test Actually Measures

When ultraviolet B rays hit your skin, or when you eat vitamin D-rich foods or take supplements, your body produces vitamin D. Your liver then converts it into 25(OH)D, the storage form that circulates in your blood. About 85 to 90% of it travels bound to a carrier protein called vitamin D-binding protein, with less than 1% floating freely. This stored form is not biologically active on its own. Your kidneys (and many other tissues) convert it into the active hormone, calcitriol (sometimes called 1,25-dihydroxy vitamin D), which is what actually regulates calcium absorption, bone remodeling, and immune function.

The conversion from vitamin D to 25(OH)D in the liver is not tightly controlled, so your blood level rises and falls in direct proportion to how much vitamin D you are getting from sun exposure, diet, and supplements. That is exactly what makes it such a useful test: it tracks your total vitamin D supply without the complex hormonal regulation that makes the active form misleading as a status marker.

Bone Health and Fracture Risk

The most firmly established consequence of low vitamin D is weakened bones. When your 25(OH)D drops too low, your body cannot absorb enough calcium from food. To keep blood calcium levels stable (which is essential for your heart and nerves), your parathyroid glands ramp up production of parathyroid hormone (PTH), which pulls calcium out of your bones. Over time, this leads to thinning, softening, and increased fracture risk.

In children, severe deficiency causes rickets, a condition where bones become soft and deformed. In adults, the equivalent condition is called osteomalacia, where bones ache and break more easily. Even before these extremes, chronically low levels accelerate bone loss and contribute to osteoporosis, particularly in older adults. The American Geriatrics Society recommends maintaining levels of at least 30 ng/mL in older adults at risk for falls and fractures.

Mortality Risk

Large studies consistently link low 25(OH)D to a higher risk of dying from any cause. The UK Biobank study, which followed over 365,000 people for nearly 9 years, found that those with levels below 25 nmol/L (10 ng/mL) had significantly higher rates of death from all causes, cardiovascular disease, and cancer compared to those at 60 nmol/L (24 ng/mL) or above.

A European meta-analysis of nearly 27,000 people using standardized measurements found a graded relationship: compared to the reference group (75 to 99.99 nmol/L, or about 30 to 40 ng/mL), those in the 30 to 39.99 nmol/L range (12 to 16 ng/mL) were about 33% more likely to die during follow-up, and those below 30 nmol/L (12 ng/mL) were 67% more likely. A 14-year Korean cohort study found similar patterns, with the lowest vitamin D group facing roughly double the mortality risk compared to those in the highest group.

The mortality benefit appears to plateau. In the UK Biobank data, risk reduction leveled off around 60 nmol/L (24 ng/mL) for overall and cardiovascular death, and around 45 nmol/L (18 ng/mL) for cancer death. Getting your level above this threshold matters enormously; pushing it much higher may not add further protection.

Cardiovascular Disease

Observational studies consistently link low vitamin D to higher rates of heart disease, stroke, and cardiovascular death. A dose-response meta-analysis of prospective studies found that each 10 ng/mL increase in 25(OH)D was associated with a 10% lower risk of total cardiovascular events and a 12% lower risk of cardiovascular death. Another large meta-analysis found that people with the lowest vitamin D levels had a 34% higher risk of developing cardiovascular disease and an 86% higher risk of recurrent cardiovascular events compared to those with the highest levels.

There is an important caveat here. The VITAL trial, which randomized over 25,000 adults to vitamin D supplementation or placebo, found no reduction in cardiovascular events. This suggests that the observational association may partly reflect confounding: people with higher vitamin D levels tend to be more physically active, leaner, and healthier in ways that statistical models may not fully capture. Low vitamin D may be a marker of cardiovascular risk rather than a direct cause. Even so, correcting genuine deficiency remains important for overall health, and the observational data suggest that very low levels are at minimum a red flag worth investigating.

Cancer Associations

The strongest cancer association is with colorectal cancer. The International Colorectal Cancer Pooling Project, combining data from 17 cohorts with over 5,700 cases, found that people with levels below 30 nmol/L (12 ng/mL) had about 31% higher colorectal cancer risk compared to the lower range of sufficiency (50 to 62.5 nmol/L, or 20 to 25 ng/mL). Those with levels in the 87.5 to 100 nmol/L range (35 to 40 ng/mL) had about 27% lower risk than the reference group.

A large Japanese case-cohort study found that the highest vitamin D quartile was associated with a 22% lower risk of overall cancer and a striking 55% lower risk of liver cancer. A Korean cohort of over 46,000 adults confirmed these patterns, showing a 20% lower overall cancer risk and a 68% lower liver cancer risk in the highest versus lowest quartile. Breast cancer shows a more modest association (about 11% lower risk per 10 ng/mL increase), while prostate cancer shows no meaningful relationship with vitamin D levels.

Type 2 Diabetes

A meta-analysis of 21 prospective studies covering over 76,000 people found that those with the highest vitamin D levels had 38% lower odds of developing type 2 diabetes compared to those with the lowest. Each 10 nmol/L (4 ng/mL) increase was associated with about 4% lower risk.

Randomized trial data support this, at least in people who already have prediabetes. A meta-analysis of three clinical trials found that vitamin D supplementation reduced new-onset diabetes by 15%. The effect was strongest in those who achieved and maintained the highest blood levels: people who reached 125 nmol/L (50 ng/mL) or above had a 76% lower risk compared to those between 50 and 74 nmol/L (20 to 30 ng/mL). If your blood sugar is trending upward, knowing your vitamin D status becomes especially relevant.

Respiratory Infections

A meta-analysis of 24 observational studies found that people with the lowest vitamin D levels were about 83% more likely to develop acute respiratory infections and nearly 2.5 times more likely to experience severe infections compared to those with the highest levels. The relationship was nonlinear, with the sharpest increase in risk occurring when levels fell below 50 nmol/L (20 ng/mL). If you catch every cold that circulates or struggle with recurrent respiratory infections, low vitamin D is worth ruling out.

Reference Ranges

No other common blood test generates as much debate about what counts as "normal." Major guidelines disagree on the threshold that separates sufficiency from deficiency, and the answer depends partly on what outcome you care about. Lab-to-lab variability in the test itself adds another layer of complexity, with different assay methods sometimes producing results that differ by 4 to 5 ng/mL for the same sample. Always compare your results within the same lab over time rather than relying on any single cutpoint.

These tiers are drawn from published guidelines and large population studies. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. Recent mortality analyses suggest that the optimal range may vary by age: roughly 27 ng/mL for adults aged 40 to 59, and closer to 42 ng/mL for those 60 and older.

Why So Many People Are Low

Your skin makes vitamin D when exposed to UVB rays, but modern life conspires against this. Indoor work, sunscreen use, clothing, higher latitudes, darker skin pigmentation, and winter months all reduce production. NHANES data from 2011 to 2014 showed that about 5% of the U.S. population had levels below 12 ng/mL (at risk of deficiency) and an additional 18% fell in the 12 to 20 ng/mL range (at risk of inadequacy), meaning roughly one in four Americans had suboptimal levels. Black Americans face the highest rates, with about 17.5% in the deficient range, due to greater melanin content reducing vitamin D production in the skin.

Body fat plays a surprisingly large role. Vitamin D is fat-soluble, meaning it gets trapped in fat tissue and becomes less available in the bloodstream. People with obesity typically have levels of 10 to 20 ng/mL. Kidney disease also impairs vitamin D metabolism, with deficiency prevalence increasing substantially as kidney function declines.

Tracking Your Trend

A single vitamin D reading gives you a useful starting point, but tracking over time is where the real value lies. Your level fluctuates by roughly 7% within a six-week window due to normal biological variation, and by up to 15% over several years. Seasonal swings add another 20% shift between summer and winter in most temperate climates. A single winter reading of 22 ng/mL might look fine in isolation but could mean your summer peak barely reaches 27 ng/mL and your true nadir dips into deficiency territory.

If you are starting supplementation or making lifestyle changes, get a baseline reading, then retest in 8 to 12 weeks to see if you are responding. After that, at least annual monitoring catches seasonal dips and confirms your dose is still working. For the most representative average, draw your blood in spring or fall, which minimizes seasonal confounding. If you are tracking a specific intervention, try to draw at the same time of year each time.

When Results Can Be Misleading

Acute illness and surgery can drop your 25(OH)D by up to 40% within two days, and levels may stay depressed for months. This happens because inflammation reduces production of vitamin D-binding protein and shifts vitamin D metabolism. If you have a blood draw during or shortly after a significant illness, surgery, or hospitalization, your result may substantially underestimate your true baseline. Wait at least several weeks after recovery before testing.

Intense exercise can temporarily raise 25(OH)D by releasing stored vitamin D from muscle and fat tissue. The effect lasts up to 24 hours and is more pronounced in men. If you want a reading that reflects your resting baseline, avoid vigorous exercise the day before your blood draw.

Several common medications can shift your reading. Corticosteroids lower 25(OH)D by about 0.5 ng/mL on average and roughly double the odds of deficiency. Anticonvulsants such as carbamazepine, phenytoin, and valproate lower levels by about 4 ng/mL by speeding up vitamin D breakdown in the liver. Long-term proton pump inhibitor (PPI) use has been associated with very high rates of deficiency, likely by reducing vitamin D absorption in the gut. If you take any of these medications, your measured level may be lower than it would otherwise be, and you may need higher supplementation doses to reach your target.

One reassuring point: your vitamin D level barely changes over the course of a day (shifting by only about 0.19 ng/mL over a 24-hour cycle), and fasting status does not meaningfully affect results. You do not need to fast or time your draw to a specific hour of the day.

Assay Variability

Different lab methods can produce results that differ by 4 to 5 ng/mL or more for the same blood sample. Immunoassay platforms (the most common method) tend to be less accurate than liquid chromatography-tandem mass spectrometry (a more precise laboratory technique often called LC-MS/MS), which is considered the gold standard. The Vitamin D Standardization Program has improved consistency, but only about half of commercial assays currently meet the target of 10% or less measurement uncertainty. This means a result of 28 ng/mL at one lab might come back as 23 or 33 ng/mL at another. The practical takeaway: use the same lab for serial measurements, and do not make major clinical decisions based on a single borderline result.